Pangen Signs Raw Material Pharmaceutical Supply Contract Worth 300 Million KRW
[Asia Economy Reporter Oh Ju-yeon] PanGen announced on the 6th that it has signed a raw material pharmaceutical supply contract worth 300 million KRW with Malaysia's Duopharma (M) SDN.BHD. This corresponds to 10.81% of recent sales revenue.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Blue House Official Criticizes National Cohesion Committee for Delayed Submission... Lee Seok-yeon Responds: "In 40 Years of Service, I've Never Seen Such Rudeness"
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
